Association of immunotherapy duration with overall survival in advanced non–small cell lung cancer – this study is being released to coincide with a poster presentation at the 2023 ASCO annual meeting
About The Study: The findings of this study provide reassurance that for patients with advanced non–small cell lung cancer whose disease ...